SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible
Securities Fraud Violations by the Board of Directors of Stryker Corporation
Levi & Korsinsky announces it has commenced an investigation of Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK)
concerning possible violations of federal securities laws.
On July 17, 2017, the U.S. Food and Drug Administration issued a warning letter to Stryker citing “violations of current good
manufacturing practice (CGMP) regulations for finished pharmaceuticals.” Then on August 23, 2017, Stryker Corporation announced a
“voluntary product recall involving specific lots of Oral Care products sold through the company’s Sage Products business unit
(Sage).” The recall is due to a potential for “cross-contamination of Oral Care solutions” by a third-party supplier. To obtain
additional information, go to:
http://www.zlkdocs.com/SYK-Info-Request-Form-6053
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar
outcomes.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20170824005795r1&sid=mstr1&distro=nx&lang=en)
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170824005795/en/